+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

2019 Sinusitis Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • PDF Icon

    Report

  • 179 Pages
  • April 2019
  • Region: Global
  • VPA Research
  • ID: 4768033
The global clinical trial report- “2019 Sinusitis Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Sinusitis. It presents in-depth analysis of Sinusitis clinical trials across markets and companies. The research work is for providing complete understanding into trends in Sinusitis.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Sinusitis clinical trials by:
  • Current Trial Status

  • Type of the trial

  • Sponsor Type

  • Enrollment Trends

  • Region

  • Countries

  • Trial Phase



The report also identifies the potential drug candidates under development for treatment of Sinusitis

The research work is prepared through extensive and continuous research on Sinusitis trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.

  • Drug candidates currently being researched for administering Sinusitis patients are identified

  • The report includes panorama of Sinusitis clinical trials across the globe

  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided

  • Companies and universities focusing on Sinusitis clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)

  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included

  • Both interventional and observational studies are analyzed

  • News and latest developments for the past one year are presented in the report

Table of Contents

1.1 List of Figures1.2 List of Tables
2. Executive Summary
2.1 Sinusitis Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Sinusitis Clinical Trials by Region
2.2.2 Average Enrollment of Sinusitis Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Sinusitis Treatment, 2019
3. Region wise Sinusitis Clinical Trials
3.1 Asia Pacific Sinusitis Clinical Trials by Country
3.2 Europe Sinusitis Clinical Trials by Country
3.3 North America Sinusitis Clinical Trials by Country
3.4 Middle East and Africa Sinusitis Clinical Trials by Country
3.5 South and Central America Sinusitis Clinical Trials by Country
4. Sinusitis Clinical Trial Trends
4.1 Start Year wise Sinusitis Clinical Trials
4.2 Phase wise Sinusitis Clinical Trials
4.3 Trial Status wise Sinusitis Clinical Trials
4.4 Trial Type wise Sinusitis Clinical Trials
5. Sinusitis Average Enrollment Trends
5.1 Average Enrollment in Sinusitis Trials by Year
5.2 Average Enrollment in Sinusitis Trials by Phase
5.3 Average Enrollment in Sinusitis Trials by Status
5.4 Average Enrollment in Sinusitis Trials by Type of Trial
6. Companies Participating in Sinusitis Clinical Trials
6.1 Sinusitis Trials by Sponsor Type
6.2 Sinusitis Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors
7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Sinusitis Trials- Phase 1
7.2 Sinusitis Trials- Phase 2
7.3 Sinusitis Trials- Phase 3
7.4 Sinusitis Trials- Phase 4
8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise
List of Figures
Figure 1: Sinusitis Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Sinusitis Clinical Trials and Enrolment
Figure 5: Europe - Country wise Sinusitis Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Sinusitis Clinical Trials and Enrolment
Figure 7: North America - Country wise Sinusitis Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Sinusitis Clinical Trials and Enrolment
Figure 9: Sinusitis Clinical Trials by Phase
Figure 10: Sinusitis Clinical Trials by Trial Status
Figure 11: Sinusitis Clinical Trials by Type
Figure 12: Sinusitis Clinical Trials by Sponsor Type
Figure 13: Sinusitis Clinical Trials by Leading Sponsors
Figure 14: Sinusitis Average Enrollment by Phase
Figure 15: Sinusitis Average Enrollment by Trial Status
Figure 16: Sinusitis Average Enrollment by Type
Figure 17: Sinusitis- Average Enrolment by Type of Sponsors
Figure 18: Sinusitis- Enrolment by Leading Sponsors
Figure 19: Research Methodology
List of Tables
Table 1: Sinusitis Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Sinusitis Clinical Trials and Enrolment
Table 5: Europe - Country wise Sinusitis Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Sinusitis Clinical Trials and Enrolment
Table 7: North America - Country wise Sinusitis Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Sinusitis Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Sinusitis Average Enrollment by Phase
Table 15: Sinusitis Average Enrollment by Trial Status
Table 16: Sinusitis Average Enrollment by Type
Table 17: Sinusitis- Average Enrolment by Type of Sponsors
Table 18: Sinusitis- Enrolment by Leading Sponsors